Speaking at the ZF Pharma Summit ’14, Sztaniszlav, who is also president of Local American Working Group, said in Romania, the access to innovation is way behind that in other EU countries. He pointed out that the Romanian state ought to make a strategic decision to provide financing so that Romania can capitalize on innovation.
Sztaniszlav went on saying that it is inevitable to boost public investments in this sector, because this is something that has not been done in the last four to five years.
He said this situation affects companies’ decisions to invest in Romania, adding that production goes hand in hand with investments in a country which further create new jobs that entail high professional training.